Use of M-CSF to improve lipoprotein cholesterol profiles
US5021239A · kind A · utility
6Cited by
0References
1Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 8, 1988 |
| Grant date | Jun 4, 1991 |
| Priority date | — |
| Expiry date | Dec 8, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are presented for improving the lipoprotein cholesterol profile of a mammal. Methods are also presented for removing atherosclerotic lesions from a mammal that has such lesions. The methods comprise administering to the mammal a therapeutic amount of an M-CSF protein in combination with a pharmaceutically acceptable excipient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.